Results: 16

Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment

An. bras. dermatol; 93 (6), 2018

Miocardiopatia não compactada em gestante com linfoma não Hodgkin. Relato de caso

A miocardiopatia não compactada é uma doença congênita rara, que pode ocorrer isoladamente ou associada a outros defeitos, por falha no processo de compactação das fibras miocárdicas, resultando na persistência de trabeculações e recessos profundos. A associação entre a miocardiopatia não co...

Immunostimulatory monoclonal antibodies for hepatocellular carcinoma therapy: Trends and perspectives

Medicina (B.Aires); 78 (1), 2018
Hepatocellular carcinoma (HCC) is the second cause of cancer-related death in the world and is the main cause of death in cirrhotic patients. Unfortunately, the incidence of HCC has grown significantly in the last decade. Curative treatments such as surgery, liver transplantation or percutaneous ablation...

Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies

Clinics; 73 (supl.1), 2018
Noncolorectal gastrointestinal (GI) malignancies are among the most frequently diagnosed cancers. Despite the undeniable progress in systemic treatments in recent decades, further improvements using cytotoxic chemotherapy seem unlikely. In this setting, recent discoveries regarding the mechanism underlyi...

Cancer immunology and melanoma immunotherapy

An. bras. dermatol; 92 (6), 2017
Abstract: The stimulation of the immune system, in order to generate an attack against cancer cells, similarly to that which occurs in infectious disease, has long been matter of interest in oncology; however, only limited success has been achieved, with different treatment strategies tested in recent ye...

Nuevas posibilidades terapéuticas en melanoma metastásico
Novel therapeutics possibilities for metastatic melanoma

El melanoma ha experimentado un aumento constante en su tasa de incidencia en las últimas cinco décadas a nivel mundial. El pronóstico del paciente con melanoma se relaciona con el estadio de la enfermedad al momento del diagnóstico, con una sobrevida global media de 6,2 meses en pacientes con melano...